H2BC21 and breast cancer: We chose to target HIST1H2BO since 1) the H2BE76K mutation was found in this H2B gene in breast cancer (Table S1) and 2) to minimize CRISPR/Cas9 off-target effects, as the sgRNAs targeting this H2B gene had the highest predicted specificity scores.